HK1038743A1 - Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use asa drug or diagnostic agent. - Google Patents
Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use asa drug or diagnostic agent.Info
- Publication number
- HK1038743A1 HK1038743A1 HK01109164A HK01109164A HK1038743A1 HK 1038743 A1 HK1038743 A1 HK 1038743A1 HK 01109164 A HK01109164 A HK 01109164A HK 01109164 A HK01109164 A HK 01109164A HK 1038743 A1 HK1038743 A1 HK 1038743A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparing
- diagnostic agent
- imidazole derivatives
- use asa
- biphenylsulfonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19832428A DE19832428A1 (de) | 1998-07-18 | 1998-07-18 | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
PCT/EP1999/004887 WO2000003996A1 (fr) | 1998-07-18 | 1999-07-10 | Derives d'imidazole a substitution biphenylsulfonyle, leur procede de preparation et leur utilisation comme medicament ou agent diagnostique |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1038743A1 true HK1038743A1 (en) | 2002-03-28 |
Family
ID=7874574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01109164A HK1038743A1 (en) | 1998-07-18 | 2001-12-28 | Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use asa drug or diagnostic agent. |
Country Status (19)
Country | Link |
---|---|
US (1) | US6369236B1 (fr) |
EP (1) | EP1097141B1 (fr) |
JP (1) | JP4567885B2 (fr) |
KR (1) | KR20010071957A (fr) |
CN (1) | CN1211370C (fr) |
AR (1) | AR019405A1 (fr) |
AT (1) | ATE362920T1 (fr) |
AU (1) | AU764438B2 (fr) |
BR (1) | BR9912241A (fr) |
CA (1) | CA2338059A1 (fr) |
DE (2) | DE19832428A1 (fr) |
HK (1) | HK1038743A1 (fr) |
HU (1) | HUP0102607A3 (fr) |
ID (1) | ID27774A (fr) |
PL (1) | PL345585A1 (fr) |
RU (1) | RU2246488C2 (fr) |
TR (1) | TR200100134T2 (fr) |
WO (1) | WO2000003996A1 (fr) |
ZA (1) | ZA200100278B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19832428A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19832429A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE10206354A1 (de) * | 2002-02-14 | 2003-08-28 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des Natrium-abhängigen Chlorid-Bicarbonat-Austauschers zur Behandlung von thrombotischen und inflammatorischer Erkrankungen |
US20030220383A1 (en) * | 2002-02-14 | 2003-11-27 | Aventis Pharma Deutschland Gmbh | Use of inhibitors of the sodium-dependent chloride/bicarbonate exchanger for the treatment of thrombotic and inflammatory disorders |
CA2691662A1 (fr) | 2007-07-02 | 2009-01-08 | F. Hoffmann-La Roche Ag | Derives imidazoles comme antagonistes du recepteur ccr2 |
US8236843B2 (en) | 2008-09-02 | 2012-08-07 | Elder Pharmaceuticals Ltd. | Anti inflammatory compounds |
KR101044953B1 (ko) * | 2009-01-07 | 2011-06-29 | (주) 인우 코퍼레이션 | 이중분사노즐을 이용한 악취제거 시스템 |
SG11201610815PA (en) * | 2014-06-23 | 2017-02-27 | Nissan Chemical Ind Ltd | Method for producing silane compound having sulfonyl bond |
WO2018002673A1 (fr) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Nouvelles formulations d'antagonistes du récepteur de l'angiotensine ii |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5126342A (en) * | 1990-10-01 | 1992-06-30 | Merck & Co., Inc. | Imidazole angiotensin ii antagonists incorporating acidic functional groups |
CA2058198A1 (fr) * | 1991-01-04 | 1992-07-05 | Adalbert Wagner | Procede de preparation et utilisation de derives d'azole |
JP3290657B2 (ja) * | 1991-05-01 | 2002-06-10 | メルク エンド カムパニー インコーポレーテッド | アンギオテンシンii拮抗剤として活性な酸性アラルキルトリアゾール誘導体 |
TW215434B (fr) * | 1992-03-07 | 1993-11-01 | Hoechst Ag | |
US5310929A (en) * | 1992-08-06 | 1994-05-10 | E. I. Du Pont De Nemours And Company | Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists |
FR2711367B1 (fr) * | 1993-10-19 | 1995-12-01 | Roussel Uclaf | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
FR2711368B1 (fr) * | 1993-09-16 | 1996-01-05 | Roussel Uclaf | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
FR2716883B1 (fr) * | 1994-03-04 | 1996-04-26 | Roussel Uclaf | Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant. |
FR2716882B1 (fr) | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques. |
DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
EP0855392A3 (fr) * | 1997-01-22 | 2000-01-05 | Hoechst Aktiengesellschaft | Hétérocycles à cinq chaínons contenant des substituants biphénylylsulphoniques, leur procédé de préparation, leur utilisation comme médicament ou agent diagnostique ainsi que médicament les contenant |
DE19832428A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19832429A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1998
- 1998-07-18 DE DE19832428A patent/DE19832428A1/de not_active Withdrawn
-
1999
- 1999-07-10 CA CA002338059A patent/CA2338059A1/fr not_active Abandoned
- 1999-07-10 WO PCT/EP1999/004887 patent/WO2000003996A1/fr not_active Application Discontinuation
- 1999-07-10 DE DE59914347T patent/DE59914347D1/de not_active Expired - Lifetime
- 1999-07-10 KR KR1020017000752A patent/KR20010071957A/ko not_active Application Discontinuation
- 1999-07-10 JP JP2000560103A patent/JP4567885B2/ja not_active Expired - Fee Related
- 1999-07-10 RU RU2001104449/04A patent/RU2246488C2/ru not_active IP Right Cessation
- 1999-07-10 BR BR9912241-3A patent/BR9912241A/pt not_active Application Discontinuation
- 1999-07-10 AT AT99938222T patent/ATE362920T1/de not_active IP Right Cessation
- 1999-07-10 AU AU52807/99A patent/AU764438B2/en not_active Ceased
- 1999-07-10 EP EP99938222A patent/EP1097141B1/fr not_active Expired - Lifetime
- 1999-07-10 HU HU0102607A patent/HUP0102607A3/hu unknown
- 1999-07-10 TR TR2001/00134T patent/TR200100134T2/xx unknown
- 1999-07-10 US US09/743,957 patent/US6369236B1/en not_active Expired - Lifetime
- 1999-07-10 CN CNB998087416A patent/CN1211370C/zh not_active Expired - Fee Related
- 1999-07-10 PL PL99345585A patent/PL345585A1/xx not_active Application Discontinuation
- 1999-07-10 ID IDW20010129A patent/ID27774A/id unknown
- 1999-07-15 AR ARP990103486A patent/AR019405A1/es not_active Application Discontinuation
-
2001
- 2001-01-10 ZA ZA200100278A patent/ZA200100278B/en unknown
- 2001-12-28 HK HK01109164A patent/HK1038743A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE19832428A1 (de) | 2000-01-20 |
EP1097141A1 (fr) | 2001-05-09 |
PL345585A1 (en) | 2001-12-17 |
CA2338059A1 (fr) | 2000-01-27 |
AR019405A1 (es) | 2002-02-20 |
DE59914347D1 (de) | 2007-07-05 |
ID27774A (id) | 2001-04-26 |
EP1097141B1 (fr) | 2007-05-23 |
AU5280799A (en) | 2000-02-07 |
CN1211370C (zh) | 2005-07-20 |
AU764438B2 (en) | 2003-08-21 |
HUP0102607A2 (hu) | 2002-03-28 |
CN1309645A (zh) | 2001-08-22 |
US6369236B1 (en) | 2002-04-09 |
ZA200100278B (en) | 2001-08-06 |
KR20010071957A (ko) | 2001-07-31 |
JP4567885B2 (ja) | 2010-10-20 |
BR9912241A (pt) | 2001-04-10 |
HUP0102607A3 (en) | 2002-05-28 |
TR200100134T2 (tr) | 2001-07-23 |
RU2246488C2 (ru) | 2005-02-20 |
ATE362920T1 (de) | 2007-06-15 |
JP2002520399A (ja) | 2002-07-09 |
WO2000003996A1 (fr) | 2000-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1044945A1 (en) | 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use. | |
ZA200201511B (en) | 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents. | |
MXPA02001497A (es) | Derivados de 3-(5)-ureido-pirazol, procedimiento para su preparacion y sus uso como agentes antitumorales. | |
AU3956900A (en) | Substituted imidazoles, their preparation and use | |
ZA200007060B (en) | Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use. | |
AU1393000A (en) | 1,4-diazabicyclo(3.2.2)nonane derivatives, their preparation and therapeutic application | |
ZA200003680B (en) | Triazole and imidazole derivatives. | |
HK1009814A1 (en) | Five-membered heterocycles having biphenylsulfonylsubstitution, process for their prparation, their use as a medicament or diagnostic, and medicament . | |
HUP0105039A3 (en) | Fungicidal propargylether derivatives, preparation and use thereof | |
HK1015789A1 (en) | Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use. | |
ZA200001746B (en) | 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use. | |
ZA200003706B (en) | Cyclobutene derivatives, their preparation and their therapeutic uses. | |
HUP0201874A3 (en) | Pesticidal indazole and benzotriazole derivatives, preparation and use thereof | |
HK1038743A1 (en) | Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use asa drug or diagnostic agent. | |
HK1049655A1 (en) | Substituted norbornylamino derivatives, productionand use thereof and medicaments containing them. | |
AU4787899A (en) | Methods, apparatuses and imaging mode for tomographic imaging | |
HK1038352A1 (en) | Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them. | |
WO1999042139A3 (fr) | Conjugues d'amidon hydroxyethyle, leur procede de production et produits pharmaceutiques les contenant | |
HUP9904659A3 (en) | Arylcarboxylic acid and tetrazole derivatives, their use and medicaments contg. them | |
HUP0201552A3 (en) | Quaternary ammonium derivatives, method for preparing the same and their pharmaceutical use | |
ZA976735B (en) | Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them. | |
IL130420A (en) | Erythromycin derivatives, method for preparing them and their use as medicine | |
HUP0203045A3 (en) | 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use | |
MXPA03007634A (es) | Derivados de imidazolidina, su preparacion, su uso y preparaciones farmaceuticas que los contienen. | |
AU2197695A (en) | Dimeric benzimidazole derivatives, their preparation and their use as dopaminergic agents, esp. selective for the dopamine d3 receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20090710 |